333

DT&CRO

No trades
See on Supercharts
Market capitalization
‪102.04 B‬KRW
−1240KRW
‪−16.64 B‬KRW
‪26.59 B‬KRW
‪6.65 M‬
Beta (1Y)
2.16

About DT&CRO

CEO
Chae-Kyu Park
Website
Headquarters
Yongin-si
Employees (FY)
329
Founded
2017
ISIN
KR7383930005
FIGI
BBG019X089X8
DT&CRO Co. Ltd. engages in the research and development of medicine and pharmaceuticals. It provides a full-service series of consignment studies ranging from non-clinical GLP toxicity, PK, and efficacy tests to analysis, livelihood, clinical trials, and licensing consultations required for licensing medicines, chemicals, health-function foods, cosmetics, and medical devices. The company was founded on April 3, 2017 and is headquartered in Yongin-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 383930 is 7840 KRW — it has decreased by 1.88% in the past 24 hours. Watch DT&CRO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DT&CRO stocks are traded under the ticker 383930.
383930 stock is 7.28% volatile and has beta coefficient of 2.16. Track DT&CRO stock price on the chart and check out the list of the most volatile stocks — is DT&CRO there?
Yes, you can track DT&CRO financials in yearly and quarterly reports right on TradingView.
383930 stock has risen by 28.31% compared to the previous week, the month change is a 0.64% rise, over the last year DT&CRO has showed a 35.17% increase.
383930 net income for the last quarter is ‪−12.79 B‬ KRW, while the quarter before that showed ‪−2.75 B‬ KRW of net income which accounts for −364.55% change. Track more DT&CRO financial stats to get the full picture.
No, 383930 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 383930 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DT&CRO stock right from TradingView charts — choose your broker and connect to your account.
383930 reached its all-time high on Jan 9, 2024 with the price of 24400 KRW, and its all-time low was 3420 KRW and was reached on Nov 15, 2023. View more price dynamics on 383930 chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 329.00 employees. See our rating of the largest employees — is DT&CRO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DT&CRO technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DT&CRO stock shows the sell signal. See more of DT&CRO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DT&CRO EBITDA is ‪−12.32 B‬ KRW, and current EBITDA margin is −46.35%. See more stats in DT&CRO financial statements.